ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

HEPA Company Profile and Key Details

NASDAQ : HEPA

Hepion Pharmaceuticals, Inc.

$0.42

-0.0091-2.11%

Open: 4:00 PM

67.73

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

HEPA Stock Price Chart

Stock Price Today

Hepion Pharmaceuticals, Inc. (HEPA) stock declined over -2.11%, trading at $0.42 on NASDAQ, down from the previous close of $0.43. The stock opened at $0.42, fluctuating between $0.41 and $0.62 in the recent session.

Stock Snapshot

0.4311

Prev. Close

0.42

Open

4.63M

Market Cap

10.98M

Number of Shares

0.405

Day Low

0.615

Day High

N/A

P/E Ratio

70.64%

Free Float in %

-220

EPS (TTM)

1.6

Book Value

-8.96

Cash Flow per Share

23.65M

Volume

Relevant Articles

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 11, 2025	0.42	0.62	0.40	0.42	23.58M
Apr 10, 2025	0.42	0.46	0.42	0.43	3.1M
Apr 09, 2025	0.44	0.74	0.41	0.49	84.16M
Apr 08, 2025	0.42	0.46	0.40	0.41	1.14M
Apr 07, 2025	0.45	0.46	0.39	0.44	1.34M
Apr 04, 2025	0.46	0.47	0.42	0.46	1.04M
Apr 03, 2025	0.46	0.51	0.42	0.48	2.36M
Apr 02, 2025	0.59	0.70	0.46	0.48	12.88M
Apr 01, 2025	0.43	0.99	0.43	0.49	50.45M
Mar 31, 2025	0.42	0.46	0.40	0.43	613.29K
Mar 28, 2025	0.57	0.60	0.47	0.48	1.35M
Mar 27, 2025	0.61	0.65	0.58	0.61	1.58M
Mar 26, 2025	0.64	0.70	0.57	0.69	2.62M
Mar 25, 2025	0.72	0.74	0.55	0.71	3.32M
Mar 24, 2025	0.83	0.85	0.73	0.74	2.56M
Mar 21, 2025	0.78	0.83	0.72	0.80	2.89M
Mar 20, 2025	0.82	0.89	0.78	0.83	4.09M
Mar 19, 2025	0.75	0.84	0.71	0.82	6.1M
Mar 18, 2025	0.80	0.90	0.67	0.78	6.34M
Mar 17, 2025	1.12	1.17	1.01	1.04	1.69M

Contact Details

Edison, NJ 08837

United States

Website: https://www.hepionpharma.comContact: 732 902 4000

About Company

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH), as well as in nonclinical studies to reduce liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH, and has demonstrated antiviral activities towards hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.

Frequently Asked Questions

What is the current Hepion Pharmaceuticals, Inc. (HEPA) stock price?

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) stock price is $0.42 in the last trading session. During the trading session, HEPA stock reached the peak price of $0.62 while $0.41 was the lowest point it dropped to. The percentage change in HEPA stock occurred in the recent session was -2.11% while the dollar amount for the price change in HEPA stock was -$0.01.

HEPA's industry and sector of operation?

The NASDAQ listed HEPA is part of Biotechnology industry that operates in the broader Healthcare sector. Hepion Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of HEPA?

Dr. Daniel J. Trepanier Ph.D.
Senior Vice President of Drug Devel.
Dr. John Z. Sullivan-Bolyai
Part-Time Consultant
Mr. John T. Cavan
Chief Financial Officer
Dr. Stephen A. Harrison FACP, M.D.
Scientific Advisory Board Chair & Consultant Medical Director
Dr. Daren Ure Ph.D.
Chief Scientific Officer
Sharen Pyatetskaya
Director of Investor Relations
Dr. Launa J. Aspeslet Ph.D.
Chief Operating Officer
Dr. Todd M. Hobbs M.D.
Chief Medical Officer
Dr. Patrick R. Mayo Ph.D.
Senior Vice President of Clinical Pharmacology
Dr. Stephen A. Harrison M.D.
Scientific Advisory Board Chair & Consultant Medical Director
Dr. Robert T. Foster B.Sc., BSc (Pharm), Ph.D., Pharm.D.
Pres, Chief Executive Officer, Chief Scientific Officer & Director

How HEPA did perform over past 52-week?

HEPA's closing price is 8.21% higher than its 52-week low of $0.39 where as its distance from 52-week high of $117.50 is -99.64%.

How many employees does HEPA have?

Number of HEPA employees currently stands at 22.

Link for HEPA official website?

Official Website of HEPA is: https://www.hepionpharma.com

How do I contact HEPA?

HEPA could be contacted at phone 732 902 4000 and can also be accessed through its website. HEPA operates from 399 Thornall Street, Edison, NJ 08837, United States.

How many shares of HEPA are traded daily?

HEPA stock volume for the day was 23.65M shares. The average number of HEPA shares traded daily for last 3 months was 3.96M.

What is the market cap of HEPA currently?

The market value of HEPA currently stands at $4.63M with its latest stock price at $0.42 and 10.98M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	22
Beta	1.8
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology